Who owns the MARITIDE trademark?

The MARITIDE trademark is owned by Amgen Inc..

What class is the MARITIDE trademark registered in?

The MARITIDE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for MARITIDE?

The USPTO serial number for MARITIDE is 98526710.

What is the registration number for MARITIDE?

MARITIDE is registered under USPTO registration number 8393460.

Sealvo

Home Search: MARITIDEMARITIDE #98526710

Back

Updated Sep 26, 2026·19 searches this week

View on USPTO TSDR Find similar marks

MAR

USPTO Trademark Record

REGISTERED

MARITIDE

SN 98526710·Reg 8393460·Filed Apr 30, 2024

Owner Amgen Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

MARITIDE (Serial No. 98526710), Registration No. 8393460, is a registered US trademark filed on Apr 30, 2024 by Amgen Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 11, 2032

Conflict Analysis

Full conflict analysis for MARITIDE (SN 98526710) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

MARITIDE (Reg. #8393460) is a registered US trademark that has been protecting its owner, Amgen Inc., since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 30, 2024

SERIAL

98526710

REG#

8393460

REGISTERED

Aug 11, 2026

Filing Information

StatusREGISTERED

Filing DateApr 30, 2024

Serial Number98526710

Registration No.8393460

Registration DateAug 11, 2026

Status DateAug 11, 2026

Published for OppositionApr 01, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1920840

480May 07, 2026

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 09, 2026

First use in commerce: Apr 09, 2026

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

REGISTERED-PRINCIPAL REGISTER

Aug 11, 2026

REGISTERED-PRINCIPAL REGISTER

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 22, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 22, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jul 21, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

May 11, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 11, 2026

USE AMENDMENT FILED

SOU EXTENSION 1 GRANTED

Oct 29, 2025

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 29, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 28, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Oct 28, 2025

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 27, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 01, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 01, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 26, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 06, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 05, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 05, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 05, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Sep 17, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Sep 17, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

ASSIGNED TO EXAMINER

Sep 06, 2024

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Sep 06, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 06, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 06, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Apr 30, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 30, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Amgen Inc.

Additional USPTO filings from the same owner.

OTE

OTEZLA XR

97504938

Amgen Inc.

REGISTERED

LOG

LogoMark

86436105

Amgen Inc.

REGISTERED

ONP

ONPRO

86423807

Amgen Inc.

REGISTERED

EVE

EVERYONE NEEDS SCIENCE. SCIENCE NEEDS EVERYONE.

97071010

Amgen Inc.

REGISTERED

Other Marks by Elsa D. Lemoine

Additional USPTO filings handled by the same attorney of record.

OTE

OTEZLA XR

97504938

REGISTERED

LOG

LogoMark

86436105

REGISTERED

ONP

ONPRO

86423807

REGISTERED

LOG

LogoMark

90057062

REGISTERED

MARITIDE

Run a conflict check

Other Marks by Amgen Inc.

Other Marks by Elsa D. Lemoine

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company